HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jörg Striessnig Selected Research

Isradipine (Dynacirc)

10/2022Cav1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons.
1/2020Biophysical classification of a CACNA1D de novo mutation as a high-risk mutation for a severe neurodevelopmental disorder.
12/2017Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jörg Striessnig Research Topics

Disease

4Channelopathies
01/2021 - 10/2004
4Hypertension (High Blood Pressure)
01/2018 - 03/2009
3Parkinson Disease (Parkinson's Disease)
10/2022 - 12/2017
3Adenoma (Adenomas)
01/2020 - 10/2017
3congenital stationary Night blindness
09/2006 - 01/2005
2Autistic Disorder (Autism)
01/2020 - 01/2017
2Neurodevelopmental Disorders
01/2020 - 01/2018
2Autism Spectrum Disorder
01/2018 - 05/2015
2Ischemia
01/2016 - 01/2015
2Deafness (Deaf Mutism)
01/2011 - 05/2010
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2022
1Hypokalemic Periodic Paralysis (Periodic Paralysis, Hypokalemic)
10/2017
1Vitamin D Deficiency
12/2012
1Neural Tube Defects (Exencephaly)
12/2012
1Cardiac Arrhythmias (Arrythmia)
01/2011
1Jervell-Lange Nielsen Syndrome (Jervell and Lange-Nielsen Syndrome)
01/2011
1Migraine Disorders (Migraine)
07/2009
1Central Nervous System Diseases (CNS Diseases)
02/2009
1Anxiety Disorders (Anxiety Disorder)
05/2008
1Episodic Ataxia
04/2008
1Migraine with Aura (Familial Hemiplegic Migraine)
12/2004
1Bradycardia
06/2004
1Ataxia (Dyssynergia)
03/2002
1Type 2 Episodic Ataxia
03/2002

Drug/Important Bio-Agent (IBA)

6voltage-dependent calcium channel (P-Q type)IBA
07/2010 - 03/2002
4L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2019 - 01/2005
4Protein Isoforms (Isoforms)IBA
02/2009 - 10/2004
3Isradipine (Dynacirc)FDA LinkGeneric
10/2022 - 12/2017
3AldosteroneIBA
01/2020 - 10/2017
3Pharmaceutical PreparationsIBA
01/2019 - 05/2008
3Retinaldehyde (Retinal)IBA
09/2006 - 01/2005
1DihydropyridinesIBA
10/2022
1DisulfidesIBA
01/2022
11,4-dihydropyridine (dihydropyridine)IBA
01/2020
1Dopamine (Intropin)FDA LinkGeneric
12/2017
1Calcium Channels (Calcium Channel)IBA
01/2016
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
12/2012
1Delayed Rectifier Potassium ChannelsIBA
01/2011
1Antidepressive Agents (Antidepressants)IBA
05/2010
1claudin 14IBA
05/2010
1CalciumIBA
04/2008
1Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
04/2008
1Adrenergic Agents (Adrenergic Drugs)IBA
06/2004

Therapy/Procedure

3Therapeutics
01/2021 - 03/2009
1Investigational Therapies (Experimental Therapy)
01/2017